Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
104.40    1.20 (1.16%)
Bid:
104.40
Ask:
105.20
Spread: 0.80 (0.766%)
Market Cap: £171.16m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

19 Oct 2009 07:00

RNS Number : 9424A
Yule Catto & Co PLC
19 October 2009
 



Yule Catto & Co plc 

Interim Management Statement

Yule Catto & Co plc, the international producer of speciality chemicals, today issues its interim management statement for the period 1 July to 30 September 2009.

The Group delivered a strong financial performance in the third quarter, exceeding the expectations of the Board at the time of its Interim Report.

In Polymer Chemicals, monomer prices increased as expected. Volumes, which were almost 15% down in the first half of the year, were less than 10% down in the quarter compared to quarter three 2008, bettering the anticipated 10-15% decline. This, together with continued good cost control and the weak pound, meant Polymers delivered a strong third quarter.

Pharma Chemicals is seasonally weak in the third quarter due to the summer shutdown period in continental Europe. We continued to see the lower volumes in the business that we experienced through the first half, but the business remains ahead of prior year as at the end of September. 

William Blythe's performance was in line with the first half of the current year, and is well ahead of last year for the nine month period.

The Group announced a number of cost reduction initiatives with its full year 2008 results which have delivered as planned.

Good progress was made on reducing Group net debt, which fell further during the quarter. In September the Group repaid the £33M current installment of its term loans, without recourse to its three year £30M revolving bank loan facility arranged in December 2008, which remained undrawn as at the end of September.

With the strong third quarter, Group profit before tax at the nine months is now well ahead of the same period last year. Raw material price rises are putting pressure on margins, and we are working to recover this through selling prices and this looks likely to persist throughout 2010. Substantial uncertainty about the global economic situation clearly remains. There has been some customer restocking during the first nine months, and whilst Polymer volumes will be ahead for the fourth quarter, we remain cautious about volume development in 2010. For the current year though, following the strong third quarter performance of the Group, the Board now expects full year underlying profit before tax for the group to substantially exceed 2008.

19 October 2009

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Group Finance Director 

 

Hogarth Partnership Limited

Tel: 020 7357 9477

Andrew Jaques

John Olsen

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSILFESIALRLIA
Date   Source Headline
13th Jul 201210:38 amRNSChange of Auditor
6th Jul 20129:38 amRNSHolding(s) in Company
3rd Jul 20124:35 pmRNSHolding(s) in Company
2nd Jul 201212:46 pmRNSHolding(s) in Company
2nd Jul 201211:11 amRNSDirector/PDMR Shareholding
27th Jun 20127:00 amRNSTrading Statement
12th Jun 201210:30 amRNSDirector/PDMR Shareholding
8th Jun 20122:09 pmRNSDirector/PDMR Shareholding
7th Jun 20124:35 pmRNSDirector/PDMR Shareholding
25th May 201211:00 amRNSDirector Declaration
17th May 201212:22 pmRNSResult of AGM
17th May 201211:00 amRNSDirectorate Change
17th May 20127:00 amRNSInterim Management Statement
14th May 20123:47 pmRNSAnnual Information Update
17th Apr 20129:18 amRNSAnnual Financial Report
3rd Apr 20123:11 pmRNSDirector/PDMR Shareholding
2nd Apr 20127:00 amRNSMarl Site Operations
28th Mar 20125:15 pmRNSHolding(s) in Company
26th Mar 20127:00 amRNSDirector/PDMR Shareholding
23rd Mar 20127:00 amRNSDirectorate Change
19th Mar 20124:10 pmRNSDirector/PDMR Shareholding
16th Mar 20121:48 pmRNSDirector/PDMR Shareholding
16th Mar 20121:46 pmRNSDirector/PDMR Shareholding
16th Mar 20121:09 pmRNSDirector/PDMR Shareholding
14th Mar 20123:52 pmRNSDirector/PDMR Shareholding
14th Mar 20127:00 amRNSFinal Results
11th Jan 20127:00 amRNSTrading Update
9th Jan 201210:24 amRNSDirector/PDMR Shareholding
3rd Jan 20124:51 pmRNSDirector/PDMR Shareholding
1st Dec 20117:00 amRNSDisposal of Pharma Division
25th Nov 20117:00 amRNSDirectorate Change
10th Nov 20117:00 amRNSInterim Management Statement
1st Nov 20113:33 pmRNSHolding(s) in Company
31st Oct 201110:15 amRNSHolding(s) in Company
20th Oct 20112:42 pmRNSHolding(s) in Company
17th Oct 20118:20 amRNSAcquisition
28th Sep 20117:00 amRNSAnalyst and Investor Site Visit
5th Sep 20117:00 amRNSAppointment of Joint Broker
26th Aug 20117:00 amRNSHalf Yearly Report
10th Aug 20118:58 amRNSHolding(s) in Company
4th Aug 20119:02 amRNSBoard appointment
27th Jul 20111:12 pmRNSHolding(s) in Company
29th Jun 20114:46 pmRNSDirector/PDMR Shareholding
29th Jun 20114:44 pmRNSDirector/PDMR Shareholding
29th Jun 20112:17 pmRNSResult of EGM
22nd Jun 20113:59 pmRNSHolding(s) in Company
16th Jun 20114:39 pmRNSHolding(s) in Company
16th Jun 20114:37 pmRNSHolding(s) in Company
13th Jun 201111:14 amRNSNotice of EGM
9th Jun 201110:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.